Richard Nicoletti
Publications by Year
Research Areas
HER2/EGFR in Cancer Research, Monoclonal and Polyclonal Antibodies Research, GDF15 and Related Biomarkers, Kruppel-like factors research, Nutrition and Health in Aging
Most-Cited Works
- → Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy(2010)716 cited
- → Drug-sensitiveFGFR2mutations in endometrial carcinoma(2008)342 cited
- → Plasma growth differentiation factor 15 is associated with weight loss and mortality in cancer patients(2015)189 cited
- → MAP3K11/GDF15 axis is a critical driver of cancer cachexia(2015)175 cited
- → Neuregulin 1 Expression Is a Predictive Biomarker for Response to AV-203, an ERBB3 Inhibitory Antibody, in Human Tumor Models(2014)61 cited
- → Growth differentiating factor-15 (GDF-15): A potential biomarker and therapeutic target for cancer-associated weight loss(2016)55 cited
- → 23814, an Inhibitory Antibody of Ligand-Mediated Notch1 Activation, Modulates Angiogenesis and Inhibits Tumor Growth without Gastrointestinal Toxicity(2015)8 cited
- → Abstract 1153: Effective treatment of cancer associated cachexia by AV-380, a GDF15 inhibitory antibody(2015)5 cited
- → Abstract 4650: From bench to bedside: are cytokines still relevant biomarkers for staging cancer cachexia.(2013)3 cited
- → Abstract 3504: Plasma growth differentiating factor-15 (GDF-15) and other inflammatory markers are associated with weight loss and poor prognosis in cancer patients.(2013)2 cited